Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
REVIEW Sean A. Martin, Corresponding Author Sean A. Martin sean.martin@adelaide.edu.au orcid.org/0000-0001-8479-4992 Freemasons Centre for Male Health & Wellbeing, University of Adelaide, Adelaide, South Australia, Australia Correspondence: Sean A. Martin, Freemasons Foundation Centre for Men's Health, University of Adelaide, c/- South Australian Health & Medical Research Institute (SAHMRI), Lv. 7 (Nth), North Tce., Adelaide, SA 5005, Australia.
Abstract Objective To assess the safety and feasibility of aquablation in a first‐in‐man study. Aquablation is a novel minimally invasive water ablation therapy combining image guidance and robotics (AquaBeam®) for the targeted and heat‐free removal of prostatic tissue in men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
